Fact CheckerSign in

NCT05309460RecruitingPhase 4

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 12 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Randomized trial comparing risk of hospital readmission and hypertensive complications between patients managed on Labetalol compared to Nifedipine.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
600 (estimated)
First submitted
25 Mar 2022
Start date
20 Jun 2022
Primary completion date
1 May 2024
Lead sponsor
Nebraska Methodist Health System
NCT number
NCT05309460

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 600
  • From 20 Jun 2022 to the primary completion date, 1 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of moderate persistent asthma, coronary artery disease, heart failure, AV heart block, pulmonary edema

Other

  • Contraindication to either Nifedipine or Labetalol
  • HR \<60 or \>110
  • Native language other than English or Spanish

Who the study is looking for

  • Any patient admitted for delivery by cesarean or vaginal delivery at 24 weeks gestation or greater with hypertension(HTN). Hypertension will be defined during the study as either a systolic blood pressure ≥140mmHg or diastolic blood pressure ≥90mmHg on two occasions at least 4 hours apart. This definition is consistent with the ACOG definition for pregnancy related HTN. Following enrollment, treatment will be escalated at discretion of primary provider with the goal of normotension.

Age in the registry: 19 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nebraska Methodist Women's Hospital
Coordinator of this site? Confirm its status
OmahaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.